会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • VIRAL SERPIN REGULATION OF INFLAMATION
    • VIRAL SERPIN调节爆发
    • WO2004039391A1
    • 2004-05-13
    • PCT/CA2003/001682
    • 2003-10-31
    • LUCAS, Alexandra, R.MCFADDEN, Grant, D.
    • LUCAS, Alexandra, R.MCFADDEN, Grant, D.
    • A61K38/03
    • A61K38/55
    • The present invention provides for a pharmaceutical composition containing at least one compound that promotes intracellular signalling via the human urokinase plasminogen activator receptor. The compound binds the human urokinase plasminogen activator receptor, the compound binds one or more intracellular protein(s) directly or indirectly associated with intracellular signalling via human urokinase plasminogen activator receptor, and the compound binds one or more intracellular protein(s) that are modulated by urokinase plasminogen activator receptor activity. The compound is an organic or inorganic compound with a molecular weight less than 1kDa, compound is a peptide between 2 and 20 amino acids in length, and the compound is a polypeptide greater than 20 amino acids in length. The compound is an antibody or fragment thereof, the compound is a nucleic acid, and the compound is administered to humans in vivo , and to human cells ex vivo . The composition includes a pharmaceutically acceptable carrier, and the composition is administered to a human individual for the treatment of an inflamatory condition.
    • 本发明提供含有至少一种通过人尿激酶纤溶酶原激活物受体促进细胞内信号传导的化合物的药物组合物。 该化合物结合人尿激酶纤溶酶原激活物受体,该化合物通过人尿激酶纤溶酶原激活物受体直接或间接地与细胞内信号传导相关联的一种或多种细胞内蛋白质,并且该化合物结合调节的一种或多种细胞内蛋白质 通过尿激酶纤溶酶原激活物受体活性。 该化合物是分子量小于1kDa的有机或无机化合物,化合物是长度在2至20个氨基酸之间的肽,并且化合物是长度大于20个氨基酸的多肽。 化合物是抗体或其片段,化合物是核酸,并且化合物在体内施用于人体,并且离体施用于人类细胞。 组合物包括药学上可接受的载体,并且将组合物施用于人个体以治疗炎症状况。